
Emplace Research Private Limited
About Emplace Research Private Limited
Data last updated:
Emplace Research Private Limited is a private limited company based in Nizampet, Telangana, India, recognised as a startup by DPIIT. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 15 May 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73100TG2020PTC140325. Its GSTIN is 36AAFCE8962R1ZO (Telangana).
The company has an authorised share capital of ₹11,160 and a paid-up capital of ₹11,160. It is led by directors Lakshmikanth Satya Gandikota and Sridevi Khambhampaty.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sy/Pt No – 202 To 204 Hno – 7A Vertex Lakeview, Nizampet, Telangana, India – 500072.
As per the financials filed for FY 2023, the company reported a revenue of ₹12.38 Lakh. For the same year it recorded a net profit of ₹1.11 Lakh (net margin 9%) and EBITDA of ₹1.11 Lakh (EBITDA margin 9%).
Company details
Recognitions & Rankings of Emplace Research
Contact details
Emplace Research Private Limited's registered office is in Nizampet, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressSy/Pt No – 202 To 204 Hno – 7A Vertex Lakeview, Nizampet, Telangana, India – 500072
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Emplace Research Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Emplace Research Private Limited
FY 2025 filings availableEmplace Research Private Limited reported revenue of ₹12.38 Lakh for FY 2023.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹1.11 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹1.11 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 9% | ||
| Net Profit Margin | 9% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Emplace Research Private Limited, buy the company report.
Board of directors of Emplace Research Private Limited
Emplace Research has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lakshmikanth Satya Gandikota | Director | 15 May 2020 | 6 Years 5 Months | Current |
| Sridevi Khambhampaty Also directs: Shilpa Biologicals Private Limited | Director | 15 May 2020 | 6 Years 5 Months | Current |
Peer comparison
Emplace Research Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Contract Research), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Visionario Life Sciences Private Limited | ₹13.05 Lakh (FY 2024) | -37.0% | Kolhapur, Maharashtra, India | |||
| Pharexcel Consulting Private Limited | ₹12.65 Lakh (FY 2025) | -43.0% | Banglore North, Karnataka, India | |||
| D2l Clinical Solutions Private Limited | ₹12.45 Lakh (FY 2025) | -22.0% | Bangalore, Karnataka, India | |||
| Amara Research Private Limited | ₹12.44 Lakh (FY 2019) | Hyderabad, Telangana, India | ||||
| Sushruta Med-Tech Innovation Labs and Enabler Private Limited | ₹12.39 Lakh (FY 2025) | -32.0% | Bengaluru, Karnataka, India | |||
| Emplace Research Private Limitedthis company | ₹12.38 Lakh (FY 2023) | ₹1.11 Lakh | 9% | Nizampet, Telangana, India | ||
| Primero Meditech Private Limited | ₹12.27 Lakh (FY 2017) | Thane, Maharashtra, India | ||||
| Awwa Pharmaceuticals Private Limited | ₹12.24 Lakh (FY 2025) | 2.0% | Navi Mumbai, Maharashtra, India | |||
| Rmmedi Innovations Private Limited | ₹12 Lakh (FY 2023) | -67.0% | Kottayam, Kerala, India | |||
| Blue Orbit Research Private Limited | ₹11.99 Lakh (FY 2025) | 1.0% | Sheoganj, Rajasthan, India | |||
| Dr.Lahan's Laboratories Private Limited | ₹11.94 Lakh (FY 2024) | 27.0% | Secunderabad, Telangana, India |
To see the full peer comparison of Emplace Research Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Emplace Research Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Emplace Research Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Emplace Research Private Limited has 1 active EPFO establishment as of Apr 05, 2024.
GST
Emplace Research has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCE8962R1ZO | Telangana | Active | 11 Nov 2022 |
To see the full GST registrations and return filing status of Emplace Research Private Limited, buy the company report.
Recent activity
Emplace Research Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Lakshmikanth Satya Gandikota was appointed as Director on 15 May 2020.
Frequently asked questions
Emplace Research is an active private limited company based in Nizampet, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 15 May 2020 (6+ years old) and is registered under CIN U73100TG2020PTC140325.
Emplace Research has 2 current directors:
- Lakshmikanth Satya Gandikota - Director
- Sridevi Khambhampaty - Director
The latest financial statements of Emplace Research on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Emplace Research is 36AAFCE8962R1ZO, registered in Telangana.
The CIN (Corporate Identification Number) of Emplace Research is U73100TG2020PTC140325. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Emplace Research was incorporated on 15 May 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Emplace Research by revenue are Visionario Life Sciences Private Limited, Pharexcel Consulting Private Limited, D2l Clinical Solutions Private Limited, Amara Research Private Limited, Sushruta Med-Tech Innovation Labs and Enabler Private Limited and 5 more, all in the Pharma industry (Contract Research).
Lakshmikanth Satya Gandikota was appointed as Director on 15 May 2020. Sridevi Khambhampaty was appointed as Director on 15 May 2020.
Yes, Emplace Research is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Emplace Research is at SyPt No – 202 To 204 Hno – 7A Vertex Lakeview, Nizampet, Telangana, India – 500072.
Emplace Research operates in the pharma industry, in the pharma contract r and d segment.

